Surgical Robots Market Size, Share, & Forecast 2030

Surgical Robots Market Technologies and Trend Research By Product Type (Instrument & Accessories, Robotic Systems and Services), By Application (Gynecologic Surgery, General Surgery, Cardiac Surgery, Urologic Surgery, Colorectal Surgery and Head and Neck Surgery), By Control Mechanism (Direct Telemanipulator and Computer Control) and By End User (Hospitals and Ambulatory Surgical Centers) - Global Forecast till 2027Surgical robots are used for robotic-assisted surgery, a minimally invasive surgery, allowing doctors to perform many complex procedures with more flexibility, precision, and control, which is not possible with conventional techniques.

A new report on the global surgical robots market, published by Market Research Future (MRFR), pegs that this market can elevate at 18.94% CAGR during the forecast period (2016-2024).

Regarding valuation, the worth of this market can be USD 19,596.61 Mn by the end of the forecast period.Major drivers of the global surgical robots market growth are technological advancements in surgical robots and the rising preference for minimally invasive surgeries.

Other factors aiding the global surgical robots market growth include accuracy, flexibility, increasing demand for automation in the healthcare sector, increasing innovation in medical technology, rise in spending on research & development (R) in the medical sector, and increasing prevalence of different diseases.

However, some factors that can pull down the market growth include high cost of surgical robots and risks associated with robotic surgeries.Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/3025Market SegmentationThe global surgical robots market is segmented by application, control mechanism, end-user, and product type.

Regional SegmentationA geographical outlining of the global surgical robots market covers the Americas (North America & Latin America), Europe, Asia Pacific, and the Middle East & Africa (MEA).The Americas is the most important regional market as North America is the most advanced region in the world due to technological advancement and better medical facilities.

The technological advancements in surgical robots, the increasing adoption of surgical robots, the various advantages of robotic-assisted surgery, and the increase in funding for medical robot research are the key drivers of the surgical robots market.

Increasing penetration of surgical robots in ASCs and emerging markets are also supporting the growth of this market.The Surgical Robots Market  is expected to reach USD 11.8 billion by 2025 from USD 6.7 billion in 2020, at a CAGR of 12.1%.Ask for PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=256618532Market Segmentation: -The surgical robots market is segmented based on product & service into robotic systems, instruments & accessories, and services.

The instruments & accessories segment is expected to command the largest share of the market in 2020 and is estimated to grow at the highest CAGR during the forecast period.

The recurrent purchase of instruments & accessories as opposed to robotic systems, which are a one-time investment, is the major factor driving the growth of this product segment.The market is segmented into general surgery, urological surgery, gynecological surgery, orthopedic surgery, neurosurgery, and other applications based on applications.

The general surgery applications segment is estimated to command the largest share of the market in 2020, and this segment is also projected to register the highest CAGR owing to increased use of surgical robots in general procedures such as bariatric surgery, Heller myotomy, gastrectomy, hernia repair, cholecystectomy, transoral surgery, and pancreatectomy.Market Drivers: - 1 Advantages of Robotic-Assisted Surgery 2 Technological Advancements 3 Increasing Adoption of Surgical Robots 4 Increase in Funding for Medical Robot ResearchRegional Analysis: -North America is expected to dominate the global surgical robots market in 2020, the Asia Pacific region is expected to register the highest CAGR during the forecast period.

The high growth in this region can be attributed to the increasing demand from key markets such as Japan and China and the large patient population in India.

Surgical robots have long been at the forefront of medical advancement.

Surgical robots have become more common in hospitals during the last few years.

They've changed the way operations are done and improved the outcomes for both patients and doctors.Robotic-assisted surgery was created to address the shortcomings of earlier minimally invasive surgical procedures and to increase doctors' ability to perform open-heart surgery.

Anesthetists formerly used a general anesthetic or a local anesthetic in combination with a nitrous oxide delivery device.

This took a long time and required complex equipment, which made it tough for the patient.New and better surgical robots have been created, allowing these operations to be performed with far less effort while retaining the greatest levels of safety and efficacy.

Integrated circuit boards (ICBs) are employed in many different regions of the body to communicate with one another in these new-style operations.

The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.

It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.

Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.

Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.

Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.

Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size  By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.

Surgical Robots are described as a machine that executes multiple surgical tasks in a capable – captive composition system.

The need for automation in the healthcare industry is the reason for the rise in surgical robots industry.

As per Renub Research latest report, the Global Surgical Robots Market will grow and reach US$ 14.8 Billion by 2027.General surgery has experienced the advancement of minimally invasive procedure performed with a tiny incision.

As per our research findings, the surgical robotics market is expected to grow with double-digit CAGR of 11.52% from 2020 to 2027.Da Vinci is the oldest and most widely used system globally.

There are four da Vinci model available for different types of surgeries Da Vinci Si, Da Vinci X, Da Vinci Xi, and Da Vinci SP.There are many types of surgeries performed by surgical robots.

Rest of WorldAll the Companies have been covered from 3 Points•    Overview•    Recent Developments•    Sales AnalysisCompany Analysis1.

The Global Surgical Robots Market to Garner a Massive Growth of 22.75%Robotic surgery, also known as robot-assisted surgery, enables doctors to perform a wide variety of complex procedures with much more flexibility, accuracy, and control than conventional surgical techniques.

This modern form of surgery involves the use of surgical robots to improve the performance level and increase the rate of success.

These forms of surgeries are normally associated with minimally invasive surgery, which involves procedures that are performed through extremely tiny incisions.In an in-depth market report published by Market Research Future (MRFR), they reveal the various relevant information and provide a detailed analysis of the segments along with the driving factors that can impact the surgical robots market growth.

Increasing automation in the healthcare industry and proliferating demand for minimally invasive surgeries has led to the growth of the surgical robots’ market on a global scale.However, risks associated with robotic surgeries, high pricing of the surgical robots, and negative attitude towards technology can strikingly hamper the market growth.

MRFR states that the global surgical robot market is expected to garner an impressive growth of rate of 22.75% over the forecast period of 2017-2023.Avail Free Sample Copy at https://www.marketresearchfuture.com/sample_request/3025Competitive LandscapeThe global surgical robots market comprises of various noteworthy players who are constantly coming up with new and innovative solutions to further advance the device and enhance its efficiency level.

Some of the key players in the market are Medtronic, Google Life Sciences, Stryker Corporation, Mazor Robotics, Intuitive Surgical, Inc., TransEnterix, Johnson & Johnson, Hansen Medical and others.13th Feb 2019, Johnson & Johnson, a global healthcare giant, revealed its plan of acquiring Auris Health, a surgical robotics company, for a striking $3.4 billion in cash.

Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.

These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.

According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.

The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.

The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.

Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.